Is Pfizer's Partner BioNTech About to Make a Big Blunder?

BioNTech (NASDAQ:BNTX) just might be the most underappreciated biotech on the planet. The German company initially developed the COVID-19 vaccine that caught Pfizer's (NYSE:PFE) attention. Many people now refer to that vaccine as "the Pfizer vaccine," completely leaving BioNTech out.